<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>大叔快评 | wechat-feeds</title><link>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</link><description>肿瘤学临床研究及制药企业研发评述</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 21 Feb 2021 23:27:39 +0800</pubDate><image><url>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</url><title>大叔快评 | wechat-feeds</title><link>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>学习敏锐度 learning agility</title><link>https://mp.weixin.qq.com/s/JFDTja67t4qgNfC0-XIYaQ</link><description></description><content:encoded><![CDATA[学习敏锐度 learning agility]]></content:encoded><pubDate>Sun, 21 Feb 2021 21:55:05 +0800</pubDate></item><item><title>ASCO GU 2021|EV-301研究同步NEJM发表，ADC药物Enfortumab vedotin再次闪耀</title><link>https://mp.weixin.qq.com/s/jdHzcg35XoTYjJqoOpWoyA</link><description></description><content:encoded><![CDATA[ASCO GU 2021|EV-301研究同步NEJM发表，ADC药物Enfortumab vedotin再次闪耀]]></content:encoded><pubDate>Sun, 21 Feb 2021 21:55:05 +0800</pubDate></item><item><title>如何在信息投喂时代，获得相对客观的消息</title><link>https://mp.weixin.qq.com/s/r2PMAasCz4vnLpngS0f_kA</link><description></description><content:encoded><![CDATA[如何在信息投喂时代，获得相对客观的消息]]></content:encoded><pubDate>Sat, 20 Feb 2021 17:17:58 +0800</pubDate></item><item><title>为啥医托比你会进行医学沟通？</title><link>https://mp.weixin.qq.com/s/jL-JL6xwpACeUfw573LiJQ</link><description></description><content:encoded><![CDATA[为啥医托比你会进行医学沟通？]]></content:encoded><pubDate>Sat, 20 Feb 2021 17:17:58 +0800</pubDate></item><item><title>读NEJM，涨知识|早期高滴度血浆治疗预防老年人重症Covid-19</title><link>https://mp.weixin.qq.com/s/OYiigsnq_lDlUivtqEnz7w</link><description></description><content:encoded><![CDATA[读NEJM，涨知识|早期高滴度血浆治疗预防老年人重症Covid-19]]></content:encoded><pubDate>Fri, 19 Feb 2021 15:34:37 +0800</pubDate></item><item><title>读NEJM，涨知识 | 恢复期血浆能否改善重症新冠肺炎患者临床结局</title><link>https://mp.weixin.qq.com/s/llj_RYaK9vdjwNmDVFTxNw</link><description></description><content:encoded><![CDATA[读NEJM，涨知识 | 恢复期血浆能否改善重症新冠肺炎患者临床结局]]></content:encoded><pubDate>Fri, 19 Feb 2021 15:34:37 +0800</pubDate></item><item><title>读NEJM，涨知识 I 口服药物Relugolix治疗子宫肌瘤</title><link>https://mp.weixin.qq.com/s/tkkPwQxHmh6-F_01Rvybjg</link><description></description><content:encoded><![CDATA[读NEJM，涨知识 I 口服药物Relugolix治疗子宫肌瘤]]></content:encoded><pubDate>Thu, 18 Feb 2021 18:43:19 +0800</pubDate></item><item><title>《你好，李焕英》热播带来的启示 |医学事务人讲故事能力如此重要！</title><link>https://mp.weixin.qq.com/s/AZmGMjS2yjznYmC5aB5bnw</link><description></description><content:encoded><![CDATA[《你好，李焕英》热播带来的启示 |医学事务人讲故事能力如此重要！]]></content:encoded><pubDate>Thu, 18 Feb 2021 18:43:19 +0800</pubDate></item><item><title>西班牙小唱</title><link>https://mp.weixin.qq.com/s/iFvrt5YpeJMCcq7Kf7mDHg</link><description></description><content:encoded><![CDATA[西班牙小唱]]></content:encoded><pubDate>Wed, 17 Feb 2021 09:12:06 +0800</pubDate></item><item><title>晚期肾癌的一线治疗：ICI+TKI组合呈现优势</title><link>https://mp.weixin.qq.com/s/ao1v_2E57wrxT0GCX56bVg</link><description></description><content:encoded><![CDATA[晚期肾癌的一线治疗：ICI+TKI组合呈现优势]]></content:encoded><pubDate>Tue, 16 Feb 2021 21:44:32 +0800</pubDate></item><item><title>读NEJM，涨知识 I ADC药物在膀胱癌的表现</title><link>https://mp.weixin.qq.com/s/4p7iD8AI0YmY-8cFmnGmxA</link><description></description><content:encoded><![CDATA[读NEJM，涨知识 I ADC药物在膀胱癌的表现]]></content:encoded><pubDate>Mon, 15 Feb 2021 14:40:40 +0800</pubDate></item><item><title>【2737】ASCO GU 2021 |同步NEJM！“可乐”组合一线治疗晚期肾细胞癌数据惊艳</title><link>https://mp.weixin.qq.com/s/LGoR9HBJNO-Jq2c2cBjnrQ</link><description></description><content:encoded><![CDATA[【2737】ASCO GU 2021 |同步NEJM！“可乐”组合一线治疗晚期肾细胞癌数据惊艳]]></content:encoded><pubDate>Mon, 15 Feb 2021 14:40:40 +0800</pubDate></item><item><title>黄慧强教授：NK/T细胞淋巴瘤研究的中国之道</title><link>https://mp.weixin.qq.com/s/UQt0Uqrznilh-mxfDb9Ttg</link><description></description><content:encoded><![CDATA[黄慧强教授：NK/T细胞淋巴瘤研究的中国之道]]></content:encoded><pubDate>Mon, 15 Feb 2021 14:40:40 +0800</pubDate></item><item><title>读NEJM，涨知识I晚期肾癌一线CLEAR研究数据亮眼</title><link>https://mp.weixin.qq.com/s/5hK4WpYsdxNiHE9LMLb_4A</link><description></description><content:encoded><![CDATA[读NEJM，涨知识I晚期肾癌一线CLEAR研究数据亮眼]]></content:encoded><pubDate>Sun, 14 Feb 2021 11:48:26 +0800</pubDate></item><item><title>EGFR突变不可切除局部晚期NSCLC的德瓦鲁单抗巩固治疗II</title><link>https://mp.weixin.qq.com/s/6kaKaK9ldyLI6yVIuu3j-A</link><description></description><content:encoded><![CDATA[EGFR突变不可切除局部晚期NSCLC的德瓦鲁单抗巩固治疗II]]></content:encoded><pubDate>Sun, 14 Feb 2021 11:48:26 +0800</pubDate></item><item><title>【2021 ASCO-GI】林榕波教授点评NRG-GI002：帕博利珠单抗+TNT，未显著改善局部进展期直肠癌NAR评分</title><link>https://mp.weixin.qq.com/s/LbKh99JCFvr3QXRgI9Ya9A</link><description></description><content:encoded><![CDATA[【2021 ASCO-GI】林榕波教授点评NRG-GI002：帕博利珠单抗+TNT，未显著改善局部进展期直肠癌NAR评分]]></content:encoded><pubDate>Sun, 14 Feb 2021 11:48:26 +0800</pubDate></item><item><title>看药闻，涨知识｜武田抗巨细胞病毒药物III期研究详细结果</title><link>https://mp.weixin.qq.com/s/QAmuxZxR79aYS2DVQ8GBbg</link><description></description><content:encoded><![CDATA[看药闻，涨知识｜武田抗巨细胞病毒药物III期研究详细结果]]></content:encoded><pubDate>Sat, 13 Feb 2021 11:26:54 +0800</pubDate></item><item><title>特泊替尼（Tepotinib）治疗脑膜转移MET阳性NSCLC</title><link>https://mp.weixin.qq.com/s/Hs3-5Q93-f8r7-gGTBTRBw</link><description></description><content:encoded><![CDATA[特泊替尼（Tepotinib）治疗脑膜转移MET阳性NSCLC]]></content:encoded><pubDate>Sat, 13 Feb 2021 11:26:54 +0800</pubDate></item><item><title>【Cancer】老年乳腺癌保乳术后辅助治疗选择：放疗、激素治疗还是联合治疗？</title><link>https://mp.weixin.qq.com/s/tTPK73sS2vCJG-nXaXVWCA</link><description></description><content:encoded><![CDATA[【Cancer】老年乳腺癌保乳术后辅助治疗选择：放疗、激素治疗还是联合治疗？]]></content:encoded><pubDate>Sat, 13 Feb 2021 11:26:54 +0800</pubDate></item><item><title>看药闻涨知识I武田申请异体干细胞治疗</title><link>https://mp.weixin.qq.com/s/2480ApzmJgjWbOD0d0j8aA</link><description></description><content:encoded><![CDATA[看药闻涨知识I武田申请异体干细胞治疗]]></content:encoded><pubDate>Fri, 12 Feb 2021 13:38:41 +0800</pubDate></item></channel></rss>